Senior CRA - werkgeversreview Senior Clinical Research Associate bij Parexel

4,0
28 apr 2017
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

PAREXEL seems to hire very positive employee's and the overall environment is very supportive. The salaries are competitive with other CRO's and I think might be a bit higher once you're above the entry level position or coming in from another company.

Minpunten

It's a CRO so travel is the primary thing that creates CRA turnover. While they try to keep folks regionalized, it is a challenge for any CRO to do this consistently. However, they do listen to you when you are stretched too thin, but it often takes a long time to reduce the travel. As a CRA your performance is based on travel verses quality and that is a problem, but again, it's a CRO and I think that is the nature of the beast being a service industry provider. It's challenging to get everything done with the amount of travel required, this results in really good employee's often receiving the same annual increase as mediocre employee's and this does not result in positive incentives.

Ontdek andere reviews over Parexel

5,0
16 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Well trained managers that empower you, truly listen to you, and only do well if YOU do well/ they provide resources and definitely offer development opportunities to those who want them AND have demonstrated they can maintain their scoped, regular duties at a high level of quality while working on special development projects Also unlimited RTO in US

Minpunten

no bonuses and too much focus/emphasis on how many years with *Parexel*, as opposed to how many years total you have been in the industry (ex doing site management at another CRO or Sponsor group )

1,0
25 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The only pro is that they offer remote work.

Minpunten

I would give zero stars if I could, but since I can’t, I’m forced to give one. They seem to have layoffs almost every year. Their US-based pharmacovigilance team was also affected in 2024 and 2025. It really feels like a hire-and-fire culture.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle